- Report
- October 2024
- 546 Pages
Global
From €6674EUR$6,995USD£5,591GBP
- Report
- January 2024
- 307 Pages
Global
From €5375EUR$5,830USD£4,350GBP
- Report
- March 2024
- 162 Pages
Global
From €4723EUR$4,950USD£3,956GBP
- Report
- April 2024
- 349 Pages
Global
From €4723EUR$4,950USD£3,956GBP
- Report
- April 2024
- 121 Pages
Global
From €5248EUR$5,500USD£4,396GBP
- Report
- October 2024
- 188 Pages
Global
From €3382EUR$3,545USD£2,833GBP
€3758EUR$3,939USD£3,148GBP
- Report
- October 2024
- 196 Pages
Global
From €5200EUR$5,450USD£4,356GBP
- Report
- August 2024
- 137 Pages
Global
From €3720EUR$3,899USD£3,116GBP
- Report
- January 2024
- 200 Pages
Global
From €4771EUR$5,000USD£3,996GBP
- Report
- June 2024
- 177 Pages
Global
From €2385EUR$2,500USD£1,998GBP
- Report
- July 2024
- 120 Pages
Global
From €4532EUR$4,750USD£3,796GBP
- Report
- July 2024
- 150 Pages
Global
From €3578EUR$3,750USD£2,997GBP
- Report
- August 2024
- 121 Pages
Global
From €3769EUR$3,950USD£3,157GBP
- Report
- July 2024
- 146 Pages
Global
From €4294EUR$4,500USD£3,597GBP
- Report
- January 2024
- 200 Pages
Global
From €3960EUR$4,150USD£3,317GBP
- Report
- October 2024
- 73 Pages
Europe
From €3101EUR$3,250USD£2,598GBP
- Report
- February 2024
- 90 Pages
Europe
From €4532EUR$4,750USD£3,796GBP
- Report
- May 2024
- 300 Pages
Global
From €3812EUR$3,995USD£3,193GBP
- Report
- August 2024
- 150 Pages
Global
From €5677EUR$5,950USD£4,755GBP
- Report
- July 2024
- 175 Pages
Global
From €4771EUR$5,000USD£3,996GBP
The Companion Diagnostics market is a subset of the biotechnology industry that focuses on the development and commercialization of diagnostic tests that are used to identify patients who are likely to benefit from a particular therapeutic. These tests are used to identify the presence of a specific biomarker or genetic mutation that is associated with a particular therapeutic. The Companion Diagnostics market is driven by the increasing demand for personalized medicine, which is tailored to the individual patient's genetic makeup. This has led to the development of more sophisticated tests that can detect a wider range of biomarkers and mutations.
The Companion Diagnostics market is highly competitive, with a number of companies offering a range of tests. Examples of companies in the market include Roche Diagnostics, Abbott Laboratories, Qiagen, Illumina, and Thermo Fisher Scientific. Show Less Read more